Use of human embryonic stem cell-based models for male reproductive toxicity screening

Ana Krtolica1, Gnanaratnam Giritharan

  • 1SLL Sciences, StemLifeLine, Inc., San Carlos, CA 94070, USA. akrtolica@sllsciences.com

Insights

Human embryonic stem cells (hESC) offer a promising in vitro model for male reproductive toxicity screening. These cells mimic early male germ cell development, aiding infertility research and environmental exposure assessments.

Area of Science:

  • Reproductive toxicology
  • Stem cell biology
  • Developmental biology

Background:

  • Male reproductive toxicity encompasses agents affecting male reproductive system development and function, including germ cell development and spermatogenesis.
  • Despite advances, many infertility cases remain unexplained, potentially due to environmental impacts on critical gamete development stages.
  • Ethical and practical challenges hinder human tissue collection for infertility research.

Purpose of the Study:

  • To explore the potential of embryonic stem cell (ESC)-derived models for male reproductive toxicity screening.
  • To identify critical molecular targets and developmental stages for in vitro toxicity models.
  • To present human ESC (hESC) as superior models compared to mouse ESC for toxicity screening.

Main Methods:

  • Review of existing literature on ESC differentiation and similarity to primordial germ cells (PGCs).
  • Analysis of gene expression and molecular signaling pathways in ESCs.
  • Description of current hESC-based systems modeling male gamete development.

Main Results:

  • ESCs share significant similarities with PGCs in gene expression and signaling.
  • ESCs can be differentiated into PGCs and spermatids in culture.
  • Evidence highlights differences between mouse and human ESCs, favoring hESC for toxicity models.

Conclusions:

  • hESC-derived models are valuable tools for in vitro toxicity assays, overcoming limitations of human tissue collection.
  • Current hESC systems show promise for modeling male gamete development and toxicity screening.
  • Further development of these models holds significant potential for future toxicology studies.

Related Concept Videos

Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...